Supreme Court Report

Supreme Court of the United States · Official docket →

Bayer HealthCare Pharmaceuticals Inc., et al. v. Curtis Ulleseit, et al.

Paid petition · United States Court of Appeals for the Ninth Circuit, No. 19-15778, 19-15782 · judgment September 16, 2020


GVR'd · October 4, 2021
Pre-decision estimate: 2% cert probability

Before the decision, well below the 4.1% base rate, with no standout signals pointing toward a grant.

Question presented

Under 28 U.S.C. 1447(d), courts of appeals generally may not review orders remanding removed cases to state court. But Section 1447(d) also states that an “order remanding a case * * * removed pursuant to” 28 U.S.C. 1442, the federal-officer removal statute, or 28 U.S.C. 1443, the civil-rights removal statute, “shall be reviewable by appeal or otherwise.” Some courts read Section 1447(d) to create appellate jurisdiction over all issues in a district court’s remand order when the removing party included the federal-officer or civil-rights removal statutes among its bases for removal. Other courts, such as the Ninth Circuit, hold that appellate jurisdiction exists only to decide whether removal was proper under the federal-officer or civil-rights statutes. The question presented is identical to the question presented in BP p.l.c. v. Mayor & City Council of Baltimore, No. 19-1189 (argued Jan. 19, 2021): Whether 28 U.S.C. 1447(d) permits a court of appeals to review any issue encompassed in a district court’s order remanding a removed case to state court where the removing defendant premised removal in part on the federal-officer removal statute, 28 U.S.C. 1442, or the civil-rights removal statute, 28 U.S.C. 1443.

Counsel of record

For petitioner
Jennifer Laura Greenblatt
Goldman Ismail Tomaselli Brennan and Baum LLP

For respondent
Curtis Brooks Cutter
Cutter Law PC

Case

Conference history
Distributed for 2 conferences

Proceedings

  1. Aug 15 2022
    Waiver of Curtis Ulleseit, et al. not accepted for filing. (August 30, 2022)
  2. Nov 05 2021
    JUDGMENT ISSUED.
  3. Oct 04 2021
    Petition GRANTED. Judgment VACATED and case REMANDED for further consideration in light of BP p.l.c. v. Mayor and City Council of Baltimore, 593 U. S. ___ (2021).
  4. Aug 04 2021
    DISTRIBUTED for Conference of 9/27/2021.
  5. Jul 23 2021
    Reply of petitioners Bayer HealthCare Pharmaceuticals Inc., et al. filed. (Distributed)
  6. Jul 12 2021
    Response to the petition for a writ of certiorari filed.
  7. May 07 2021
    Motion to extend the time to file a response is granted and the time is extended to and including July 12, 2021.
  8. May 06 2021
    Motion to extend the time to file a response from May 13, 2021 to July 12, 2021, submitted to The Clerk.
  9. Apr 13 2021
    Response Requested. (Due May 13, 2021)
  10. Apr 07 2021
    DISTRIBUTED for Conference of 4/23/2021.
  11. Mar 09 2021
    Waiver of right of respondent Curtis Ulleseit, et al. to respond filed.
  12. Feb 12 2021
    Petition for a writ of certiorari filed. (Response due March 24, 2021)